Dynacin Related Published Studies
Well-designed clinical trials related to Dynacin (Minocycline)
Local minocycline as an adjunct to surgical therapy in moderate to severe, chronic periodontitis. [2008.06]
Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption. [2007.12.01]
Topical minocycline and tetracycline rinses in treatment of recurrent aphthous stomatitis: a randomized cross-over study. [2007.05.01]
Effect of treatment of rosacea in females by Chibixiao Recipe in combination with minocycline and spironolactone. [2006.12]
Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. [2006.10]
Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study. [2006.05]
Topical minocycline microspheres versus topical chlorhexidine gel as an adjunct to mechanical debridement of incipient peri-implant infections: a randomized clinical trial. [2006.05]
Additional minocycline pleurodesis after thoracoscopic surgery for primary spontaneous pneumothorax. [2006.03.01]
A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. [2006.03]
Longitudinal clinical evaluation of adjunct minocycline in the treatment of chronic periodontitis. [2006.02]
Supportive periodontal therapy using mechanical instrumentation or 2% minocycline gel: a 12 month randomized, controlled, single masked pilot study. [2006.02]
Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection. [2006.01]
Minocycline in amyotrophic lateral sclerosis: a pilot study. [2005.10]
A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. [2005.06]
Efficacy of subgingivally applied minocycline in the treatment of chronic periodontitis. [2005.02]
Well-designed clinical trials possibly related to Dynacin (Minocycline)
Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study. [2008.09]
Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia. [2008.07]
Serological response to chemoprophylaxis in extended contacts in leprosy--a randomized controlled trial. [2008.02]
Exposure-response analyses of tigecycline efficacy in patients with complicated intra-abdominal infections. [2008.01]
Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials. [2007.12]
Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials. [2007.10.17]
Infection reduction using antibiotic-coated inflatable penile prosthesis. [2007.08]
Exposure-response analyses of tigecycline efficacy in patients with complicated skin and skin-structure infections. [2007.06]
Predictors of efficacy and health resource utilization in treatment of complicated intra-abdominal infections: evidence for pooled clinical studies comparing tigecycline with imipenem-cilastatin. [2007.04]
A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy. [2006.03]
Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam. [2005.11]
A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744]. [2005.10.19]
The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. [2005.09.01]
Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial. [2005.09]
Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial. [2005.08]
Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. [2005.03]
Lesional characteristics and histopathology in paucibacillary leprosy patients with 2 or 3 skin lesions: comparison between ROM and PB-MDT regimens. [2005.01]
Combined effects of Nd:YAG laser irradiation with local antibiotic application into periodontal pockets. [2005.01]
Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects. [2005.01]
Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne. [2005.01]
Other research related to Dynacin (Minocycline)
Minocycline attenuates cognitive impairment and restrains oxidative stress in the hippocampus of rats with chronic cerebral hypoperfusion. [2008.10]
[Minocycline for the treatment of amyotrophic lateral sclerosis: neuroprotector or neurotoxin? Reflections on another failure of translational medicine.] [2008.10]
A re-assessment of minocycline as a neuroprotective agent in a rat spinal cord contusion model. [2008.09.24]
A double-blind randomized clinical trial of subgingival minocycline for chronic periodontitis. [2008.09]
Effects of minocycline and valproic acid coadministration on atazanavir plasma concentrations in human immunodeficiency virus-infected adults receiving atazanavir-ritonavir. [2008.09]
Chronic minocycline-induced autoimmunity in children. [2008.09]
Minocycline hepatitis. [2008.08]
Post-insult minocycline treatment attenuates hypoxia-ischemia-induced neuroinflammation and white matter injury in the neonatal rat: a comparison of two different dose regimens. [2008.08]
[Is good old minocycline a new neuroprotective drug?] [2008.07.01]
Drug-induced thyroiditis and papillary carcinoma in a minocycline-pigmented black thyroid gland. [2008.07]
Minocycline protects motor but not autonomic neurons after cauda equina injury. [2008.07]
Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis. [2008.06]
Changes in meibomian fatty acids and clinical signs in patients with meibomian gland dysfunction after minocycline treatment. [2008.06]
Severe lactic acidosis secondary to minocycline in a teenager with infectious mononucleosis and mitochondrial myopathy. [2008.06]
Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. [2008.05.13]
Minocycline treatment results in reduced oral steroid requirements in adult asthma. [2008.05]
A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results. [2008.05]
Pilot study of minocycline in relapsing-remitting multiple sclerosis. [2008.05]
Combined treatment with atorvastatin and minocycline suppresses severity of EAE. [2008.05]
Suramin and minocycline treatment of experimental African trypanososmiasis at an early stage of parasite brain invasion. [2008.04]
Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. [2008.04]
Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a high-mobility group box1-inhibiting mechanism. [2008.03]
Minocycline-induced hyperpigmentation in rheumatoid arthritis. [2008.02]
[Minocycline as a therapeutic drug for methamphetamine use disorders] [2008.02]
[Case of acute eosinophilic pneumonia probably induced by minocycline] [2008.02]
Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat-Effects on BBB breakdown and MMP expression in the acute and subacute phase. [2008.01.10]
Topical minocycline for managing symptoms of recurrent aphthous stomatitis. [2008.01]
Minocycline and N-methyl-4-isoleucine cyclosporin (NIM811) mitigate storage/reperfusion injury after rat liver transplantation through suppression of the mitochondrial permeability transition. [2008.01]
A novel role of minocycline: attenuating morphine antinociceptive tolerance by inhibition of p38 MAPK in the activated spinal microglia. [2008.01]
[Confluent and reticulated Gougerot-Carteaud papillomatosis: a case report of an excellent response to minocycline] [2008.01]
Feasibility of minocycline and doxycycline use as potential vasculostatic therapy for brain vascular malformations: pilot study of adverse events and tolerance. [2008]
Minocycline-induced DRESS: evidence for accumulation of the culprit drug. [2008]
Characterization of the antinociceptive and anti-inflammatory activities of doxycycline and minocycline in different experimental models. [2007.12.08]
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. [2007.12]
Case reports: minocycline-induced hyperpigmentation resolves during oral isotretinoin therapy. [2007.12]
Effect of minocycline on inflammation-induced damage to the blood-brain barrier and white matter during development. [2007.12]
Evolution of the inflammatory response in the brain following intracerebral hemorrhage and effects of delayed minocycline treatment. [2007.11.14]
The histopathology of subcutaneous minocycline pigmentation. [2007.11]
Hydrogen peroxide attenuates insulin-like growth factor-1 neuroprotective effect, prevented by minocycline. [2007.11]
Monitoring the protective effects of minocycline treatment with radiolabeled annexin V in an experimental model of focal cerebral ischemia. [2007.11]
Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. [2007.10.02]
Nail discoloration occurring after 8 weeks of minocycline therapy. [2007.10]
Minocycline modulates neuroinflammation independently of its antimicrobial activity in staphylococcus aureus-induced brain abscess. [2007.10]
[Case of minocycline-induced pneumonitis with bilateral pleural effusion] [2007.10]
Mechanical therapy with adjunctive minocycline microspheres reduces red-complex bacteria in smokers. [2007.09]
[Severe drug rash with eosinophilia and systemic symptoms after treatment with minocycline] [2007.09]
Minocycline HCl Microspheres Reduce Red-Complex Bacteria in Periodontal Disease Therapy. [2007.08]
The inhibitory effect of minocycline on hypertrophic scarring. [2007.07]
Prolonged bacterial exposure to minocycline/rifampicin-impregnated vascular catheters does not affect antimicrobial activity of catheters. [2007.07]
Minocycline, a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophrenia. [2007.06.18]
Minocycline-induced cutaneous polyarteritis nodosa. [2007.06]
Therapy with minocycline aggravates experimental rabies in mice. [2007.06]
Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII. [2007.05.18]
Regional differences in the neuroprotective effect of minocycline in a mouse model of global forebrain ischemia. [2007.05.08]
The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study. [2007.05]
Chronic intrathecal infusion of minocycline prevents the development of spinal-nerve ligation-induced pain in rats. [2007.05]
Hyperthyroidism and lupus-like syndrome in an adolescent treated with minocycline for acne vulgaris. [2007.05]
Papillary thyroid carcinoma in a patient with sarcoidosis treated with minocycline. [2007.05]
Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid. [2007.03.21]
Neuron death and inflammation in a rat model of intracerebral hemorrhage: effects of delayed minocycline treatment. [2007.03.09]
Protective effects of minocycline on the reduction of dopamine transporters in the striatum after administration of methamphetamine: a positron emission tomography study in conscious monkeys. [2007.03.01]
Novel chitosan wound dressing loaded with minocycline for the treatment of severe burn wounds. [2007.02.07]
Minocycline-induced lupus in adolescents: clinical implications for physical therapists. [2007.02]
Possible antipsychotic effects of minocycline in patients with schizophrenia. [2007.01.30]
Minocycline protects photoreceptors from light and oxidative stress in primary bovine retinal cell culture. [2007.01]
Minocycline delays but does not attenuate the course of experimental autoimmune encephalomyelitis in Streptococcus pneumoniae-infected mice. [2007.01]
|
